FAP and neoplasm: targeting of FAP genes to tumor-derived exosome-like nanovesicles (eNVs-FAP) triggers a potent and specific cytotoxic T-lymphocyte (CTL) immune response against both tumor cells and FAP CAFs in multiple models of Remodeling of immunosuppressive TME (116).